VIDEO: EYP-1901 shows maintenance of visual acuity, reduced treatment burden at 12 months
In this Healio Video Perspective from the Retina Society meeting, David A. Eichenbaum, MD, of Retina Vitreous Associates of Florida, presents promising 12-month results from the DAVIO 2 trial.